GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

Longevity is being framed as a consumer movement when, in reality, it is a pharmaceutical pipeline challenge. And pharma ...

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

INCHEON, South Korea, Jan. 13, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today presented key strategic priorities and clinical development updates ...

Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomarkers are ...

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

Basket Trials Evaluating Tazemetostat Combinations for Multiple New Heme and Solid Tumor Cancers to be Initiated in Second Half 2021 “The recent accelerated approvals of TAZVERIK in Epithelioid ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...

Alpha synuclein is a presynaptic protein that, when misfolded, contributes to neuronal degeneration and the progression of ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...